While it remains unclear whether RANBP9’s tumor suppressive effects is observed in vitro, most studies agree that RANBP9 is over-expressed in a variety of highly prevalent tumor types including that of NSCLC[44,45,50-52]. Here, RANBP9 is linked to non-small cell lung carcinoma.